Pharmaceutical Investing

Verrica Pharmaceuticals Dips on FDA IND Acceptance

Pharmaceutical Investing

Verrica Announces FDA Filing Acceptance of IND for VP-102

Pharmaceutical Investing

Aravive Announces Pricing of Public Offering of Common Stock

Biotech Investing

Seelos Therapeutics Begins Dosing in Phase 1 PK/KD Study

Biotech Investing

Acasti Pharma Updates on TRILOGY 1 Phase 3 Trial

Biotech Investing

Harvest One Reports Record Revenues for First Quarter 2020; Outlines Enhanced Strategic Plan Focused on Brand Development and Distribution, Cost Savings and Achieving Profitability

Cannabis Investing News

Sorrento Therapeutics Rejects Unsolicited Acquisition Proposal

Biotech Investing

Theratechnologies Announces EGRIFTA is Available in US

Biotech Investing

Zogenix Receives FDA NDA Acceptance for FINTEPLA

Pharmaceutical Investing

CymaBay Therapeutics Stops Clinical Development of Seladelpar

Biotech Investing

Avadel Pharma Reaches Enrollment Target in REST-ON Trial

Pharmaceutical Investing

Cardiol Therapeutics Comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency

Cannabis Investing News

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES